Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Melita Salković-Petrisic"'
Autor:
Jan Homolak, Ivan Kodvanj, Ana Babic Perhoc, Davor Virag, Ana Knezovic, Jelena Osmanovic Barilar, Peter Riederer, Melita Salkovic-Petrisic
Publikováno v:
MethodsX, Vol 9, Iss , Pp 101611- (2022)
We propose a rapid, simple, and robust method for measurement of the reductive capacity of liquid and solid biological samples based on potassium permanganate reduction followed by trapping of manganese dioxide precipitate on a nitrocellulose membran
Externí odkaz:
https://doaj.org/article/98a667cdeb7e4ee88254251b8cca53f3
Autor:
Jan Homolak, Ana Babic Perhoc, Ana Knezovic, Jelena Osmanovic Barilar, Davor Virag, Mihovil Joja, Melita Salkovic-Petrisic
Publikováno v:
Antioxidants, Vol 11, Iss 1, p 37 (2021)
Galactose is a ubiquitous monosaccharide with important yet incompletely understood nutritive and physiological roles. Chronic parenteral d-galactose administration is used for modeling aging-related pathophysiological processes in rodents due to its
Externí odkaz:
https://doaj.org/article/8b5bf6c0abba4a64a3adfb49682a81a4
Autor:
Jan Homolak, Ana Babic Perhoc, Ana Knezovic, Jelena Osmanovic Barilar, Melita Salkovic-Petrisic
Publikováno v:
Antioxidants, Vol 10, Iss 7, p 1118 (2021)
The gastrointestinal system may be involved in the etiopathogenesis of the insulin-resistant brain state (IRBS) and Alzheimer’s disease (AD). Gastrointestinal hormone glucagon-like peptide-1 (GLP-1) is being explored as a potential therapy as activ
Externí odkaz:
https://doaj.org/article/d410ed7161cf4a668c68f0d7d8d4fd62
Publikováno v:
Journal of Neural Transmission. 129:773-804
The novel antibiotic-exploiting strategy in the treatment of Alzheimer's (AD) and Parkinson's (PD) disease has emerged as a potential breakthrough in the field. The research in animal AD/PD models provided evidence on the antiamyloidogenic, anti- inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f8896fb3277f958a9e9d458d2bed5f
https://doi.org/10.1007/s00702-021-02457-2
https://doi.org/10.1007/s00702-021-02457-2
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 129(5-6)
The novel antibiotic-exploiting strategy in the treatment of Alzheimer's (AD) and Parkinson's (PD) disease has emerged as a potential breakthrough in the field. The research in animal AD/PD models provided evidence on the antiamyloidogenic, anti-infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ee221cc33e52cf544c62e88c78496a9
https://pubmed.ncbi.nlm.nih.gov/34982206
https://pubmed.ncbi.nlm.nih.gov/34982206
Autor:
Jan Homolak, Konstantinos Varvaras, Vittorio Sciacca, Ana Babic Perhoc, Davor Virag, Ana Knezovic, Jelena Osmanovic Barilar, Melita Salkovic-Petrisic
Publikováno v:
ACS Omega, Vol 9, Iss 10, Pp 11288-11304 (2024)
Externí odkaz:
https://doaj.org/article/9074b993145c46e7a890f79be6c689e0
Autor:
Ana Babić Perhoč, Jan Homolak, Davor Virag, Ana Knezović, Jelena Osmanović Barilar, Melita Šalković-Petrišić
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S363- (2023)
Externí odkaz:
https://doaj.org/article/201f751272524195a5a6e034f9d85c9c
Autor:
Jan Homolak, Ana Babić Perhoč, Mihovil Joja, Joke De Busscher, Miguel Zambrano Lucio, Davor Virag, Ana Knezović, Jelena Osmanović Barilar, Melita Šalković-Petrišić
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S426- (2023)
Externí odkaz:
https://doaj.org/article/a8090eed1fd84370a6ded995c5c97743
Autor:
Edna Grünblatt, Jan Homolak, Ana Babic Perhoc, Virag Davor, Ana Knezovic, Jelena Osmanovic Barilar, Peter Riederer, Susanne Walitza, Christian Tackenberg, Melita Salkovic-Petrisic
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
Alzheimer’s disease (AD) is the most common neurodegenerative disorder with the majority of patients classified as sporadic AD (sAD), in which etiopathogenesis remains unresolved. Though sAD is argued to be a polygenic disorder, apolipoprotein E (A
Externí odkaz:
https://doaj.org/article/f94e84f7932a4e569d62889b81ecb7d6
Autor:
Jelena Osmanović Barilar, Ana Babić Perhoč, Ana Knezović, Jan Homolak, Davor Virag, Melita Šalković-Petrišić
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1025 (2023)
Type 2 diabetes mellitus increases the risk of sporadic Alzheimer’s disease (sAD), and antidiabetic drugs, including the sodium–glucose cotransporter inhibitors (SGLTI), are being studied as possible sAD therapy. We have explored whether the SGLT
Externí odkaz:
https://doaj.org/article/ab0695064c9a4131b0ac1763a94b2110